These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 23137577

  • 1. Safety of bisphosphonates.
    Orozco C, Maalouf NM.
    Rheum Dis Clin North Am; 2012 Nov; 38(4):681-705. PubMed ID: 23137577
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
    McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM.
    Am J Med; 2013 Jan; 126(1):13-20. PubMed ID: 23177553
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates in the treatment of osteoporosis.
    Diab DL, Watts NB.
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):487-506. PubMed ID: 22877426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiresorptive Therapies for Osteoporosis.
    Weinerman S, Usera GL.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):555-60. PubMed ID: 26412797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Going on a drug holiday?
    Bonnick SL.
    J Clin Densitom; 2011 Aug; 14(4):377-83. PubMed ID: 22051091
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of bisphosphonates in older adults: how long is long enough?
    Dunn RL, Bird ML, Conway SE, Stratton MA.
    Consult Pharm; 2013 Jan; 28(1):39-57. PubMed ID: 23315281
    [Abstract] [Full Text] [Related]

  • 15. Benefits and potential risks of bisphosphonate therapy A narrative review.
    El Osta L, El Osta N, El Osta H.
    J Med Liban; 2016 Jan; 64(4):228-37. PubMed ID: 29845849
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
    Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J.
    Can Fam Physician; 2014 Apr; 60(4):324-33. PubMed ID: 24733321
    [Abstract] [Full Text] [Related]

  • 18. Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back.
    Salari P, Abdollahi M.
    J Pharm Pharm Sci; 2012 Apr; 15(2):305-17. PubMed ID: 22579009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Update on osteoporosis treatment. Should you stay on bisphosphonate drugs long-term?
    Harv Womens Health Watch; 2012 Aug; 19(12):6. PubMed ID: 23033551
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.